tetradecanoylphorbol acetate has been researched along with 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, JS; Han, MS; Ku, SK; Lee, MY; Lee, YM | 1 |
| Cai, H; Hua, Z; Huang, H; Shi, J; Wei, Y; Zhang, L | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one
| Article | Year |
|---|---|
Inhibitory effects of oroxylin A on endothelial protein C receptor shedding in vitro and in vivo.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Blood Coagulation Factors; Disease Models, Animal; Down-Regulation; Flavonoids; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-1beta; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Receptors, Cell Surface; Scutellaria baicalensis; Sepsis; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2014 |
Oroxylin A inhibits carcinogen-induced skin tumorigenesis through inhibition of inflammation by regulating SHCBP1 in mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Carcinogens; Cell Line; Cytokines; Female; Flavonoids; Mice, Inbred ICR; RNA, Small Interfering; Shc Signaling Adaptor Proteins; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription Factor RelA | 2020 |